Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Addus HomeCare Corporation, Progyny or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Addus HomeCare Corporation, Progyny and Inc. compare based on key financial metrics to determine which better meets your investment needs.
About Addus HomeCare Corporation, Progyny and Inc.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest Health Care Providers & Services and Addus HomeCare Corporation, Progyny, Inc. Stock News
As of July 9, 2025, Addus HomeCare Corporation had a $2.1 billion market capitalization, compared to the Health Care Providers & Services median of $969.1 million. Addus HomeCare Corporation’s stock is down 8.7% in 2025, up 1.3% in the previous five trading days and down 2.82% in the past year.
Currently, Addus HomeCare Corporation’s price-earnings ratio is 25.9. Addus HomeCare Corporation’s trailing 12-month revenue is $1.2 billion with a 6.5% net profit margin. Year-over-year quarterly sales growth most recently was 20.3%. Analysts expect adjusted earnings to reach $6.114 per share for the current fiscal year. Addus HomeCare Corporation does not currently pay a dividend.
As of July 9, 2025, Progyny, Inc. had a $2.0 billion market cap, putting it in the 58th percentile of all stocks. Progyny, Inc.’s stock is up 37.9% in 2025, up 7.8% in the previous five trading days and down 16.39% in the past year.
Currently, Progyny, Inc.’s price-earnings ratio is 41.9. Progyny, Inc.’s trailing 12-month revenue is $1.2 billion with a 4.3% net profit margin. Year-over-year quarterly sales growth most recently was 16.5%. Analysts expect adjusted earnings to reach $1.618 per share for the current fiscal year. Progyny, Inc. does not currently pay a dividend.
How We Compare Addus HomeCare Corporation, Progyny and Inc. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Addus HomeCare Corporation, Progyny and Inc.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
Addus HomeCare Corporation, Progyny and Inc.’s Quality Grades
| Company | Ticker | Quality |
| Addus HomeCare Corporation | ADUS |
B |
| Progyny, Inc. | PGNY |
A |
Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.
The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.
The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.
Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.
Addus HomeCare Corporation has a Quality Score of 61, which is Strong.
Progyny, Inc. has a Quality Score of 95, which is Very Strong.
The Quality Grade Winner: Progyny, Inc.
As you can clearly see from the Quality Grade breakdown above, Progyny, Inc. has a better overall quality grade than Addus HomeCare Corporation. For investors who are looking for companies with higher quality than others in the same industry, Progyny, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.
Addus HomeCare Corporation, Progyny and Inc.’s Momentum Grades
| Company | Ticker | Momentum |
| Addus HomeCare Corporation | ADUS |
D |
| Progyny, Inc. | PGNY |
D |
Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.
Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.
Addus HomeCare Corporation has a Momentum Score of 35, which is Weak.
Progyny, Inc. has a Momentum Score of 37, which is Weak.
The Momentum Stock Winner: No Clear Winner
Neither Addus HomeCare Corporation, Progyny or Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Addus HomeCare Corporation, Progyny or Inc. is the better investment when it comes to momentum.
Addus HomeCare Corporation, Progyny and Inc.’s Estimate Revisions Grades
| Company | Ticker | Earnings Estimate |
| Addus HomeCare Corporation | ADUS |
B |
| Progyny, Inc. | PGNY |
B |
Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).
Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.
Addus HomeCare Corporation has a Earnings Estimate Score of 61, which is Positive.
Progyny, Inc. has a Earnings Estimate Score of 70, which is Positive.
The Earnings Estimate Revisions Grade Winner: It’s a Tie!
Looking at the Earnings Estimate Revisions Grade breakdown above, both Addus HomeCare Corporation, Progyny and Inc. have a grade of B. For those focusing solely on a company’s estimate revisions, other financial metrics will need to be evaluated to determine whether Addus HomeCare Corporation, Progyny or Inc. is a better fit.
Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions
Other Addus HomeCare Corporation, Progyny and Inc. Grades
In addition to Momentum, Estimate Revisions and Quality, A+ Investor also provides grades for Value and Growth.
Invest with Confidence with A+ Investor
AAII’s expansive and robust screening tools like A+ Investor help investors make confident decisions.
Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.
Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.
These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Addus HomeCare Corporation, Progyny and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.
So, Which Is the Better Investment, Addus HomeCare Corporation, Progyny or Inc. Stock?
Overall, Addus HomeCare Corporation stock has a Momentum Score of 35, Estimate Revisions Score of 61 and Quality Score of 61.
Progyny, Inc. stock has a Momentum Score of 37, Estimate Revisions Score of 70 and Quality Score of 95.
Comparing Addus HomeCare Corporation, Progyny and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.
Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.
A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.
